Bluelinea SA (ALBLU) - Total Assets

Latest as of June 2025: €9.50 Million EUR ≈ $11.10 Million USD

Based on the latest financial reports, Bluelinea SA (ALBLU) holds total assets worth €9.50 Million EUR (≈ $11.10 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Bluelinea SA for net asset value and shareholders' equity analysis.

Bluelinea SA - Total Assets Trend (2009–2024)

This chart illustrates how Bluelinea SA's total assets have evolved over time, based on quarterly financial data.

Bluelinea SA - Asset Composition Analysis

Current Asset Composition (December 2024)

Bluelinea SA's total assets of €9.50 Million consist of 23.9% current assets and 76.1% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €92.39K 5.2%
Accounts Receivable €685.35K 7.3%
Inventory €242.05K 2.6%
Property, Plant & Equipment €1.22 Million 13.0%
Intangible Assets €3.73 Million 39.8%
Goodwill €1.99 Million 21.3%

Asset Composition Trend (2009–2024)

This chart illustrates how Bluelinea SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ALBLU stock market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Bluelinea SA's current assets represent 23.9% of total assets in 2024, a decrease from 85.3% in 2009.
  • Cash Position: Cash and equivalents constituted 5.2% of total assets in 2024, down from 16.8% in 2009.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, an increase from 10.0% in 2009.
  • Asset Diversification: The largest asset category is intangible assets at 39.8% of total assets.

Bluelinea SA Competitors by Total Assets

Key competitors of Bluelinea SA based on total assets are shown below.

Company Country Total Assets
Vitrolife AB
ST:VITR
Sweden Skr11.12 Billion
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
China CN¥805.10 Million
Tellgen Corp
SHE:300642
China CN¥2.00 Billion
Lumos Diagnostics Holdings Ltd
AU:LDX
Australia AU$20.81 Million
T&R Biofab Co. Ltd
KQ:246710
Korea ₩83.86 Billion
Ok Biotech Co Ltd
TW:4155
Taiwan NT$3.89 Billion
Promimic AB
ST:PRO
Sweden Skr75.71 Million
Memphasys Ltd
AU:MEM
Australia AU$10.45 Million

Bluelinea SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.46 0.49 1.09
Quick Ratio 0.39 0.44 0.92
Cash Ratio 0.01 0.01 0.00
Working Capital €-3.24 Million €-3.33 Million €312.69K

Bluelinea SA - Advanced Valuation Insights

This section examines the relationship between Bluelinea SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 12.71
Latest Market Cap to Assets Ratio 0.98
Asset Growth Rate (YoY) -13.5%
Total Assets €9.38 Million
Market Capitalization $9.16 Million USD

Valuation Analysis

Near Book Valuation: The market values Bluelinea SA's assets close to their book value (0.98x), suggesting investors view the company's assets at approximately fair value.

Significant Asset Reduction: Bluelinea SA's assets decreased by 13.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Bluelinea SA (2009–2024)

The table below shows the annual total assets of Bluelinea SA from 2009 to 2024.

Year Total Assets Change
2024-12-31 €9.38 Million
≈ $10.97 Million
-13.46%
2023-12-31 €10.84 Million
≈ $12.67 Million
-17.65%
2022-12-31 €13.16 Million
≈ $15.39 Million
+63.06%
2021-12-31 €8.07 Million
≈ $9.44 Million
+8.46%
2020-12-31 €7.44 Million
≈ $8.70 Million
+7.26%
2019-12-31 €6.94 Million
≈ $8.11 Million
-21.77%
2018-12-31 €8.87 Million
≈ $10.37 Million
+91123.81%
2017-12-31 €9.73K
≈ $11.37K
-21.30%
2016-12-31 €12.36K
≈ $14.45K
+25.68%
2015-12-31 €9.83K
≈ $11.49K
-99.82%
2014-12-31 €5.61 Million
≈ $6.56 Million
+67.48%
2013-12-31 €3.35 Million
≈ $3.91 Million
-4.51%
2012-12-31 €3.51 Million
≈ $4.10 Million
+108.97%
2011-12-31 €1.68 Million
≈ $1.96 Million
+443.21%
2010-12-31 €308.90K
≈ $361.14K
+33.76%
2009-12-31 €230.93K
≈ $269.98K
--

About Bluelinea SA

PA:ALBLU France Medical Devices
Market Cap
$10.07 Million
€8.61 Million EUR
Market Cap Rank
#27078 Global
#471 in France
Share Price
€0.47
Change (1 day)
+2.17%
52-Week Range
€0.44 - €0.73
All Time High
€6.30
About

Bluelinea Société Anonyme provides health services for elderly and disabled people in France. It offers seniors and home services, including day and night family, and elder support related services. The company also provides connected establishments services that protects residents while assisting caregivers and staff in shared accommodation between seniors, serviced residences, EHPADs, specializ… Read more